The present invention is related to new basically substituted ureas having the general Formula I
and the pharmaceutically acceptable acid addition salts thereof which produce an improved antiviral activity against DNS- and RNS-viruses. The invention is further related to processes for producing the same as well as to compositions containing the same as active agent used in humans and animals suffering from diseases caused by viruses.
本发明涉及具有通式 I 的新的基本取代的脲类化合物及其药物可接受的酸加成盐。
及其药学上可接受的酸加成盐,它们对 DNS 和 RNS 病毒具有更好的抗病毒活性。本发明还涉及生产上述物质的工艺以及含有上述物质的组合物,这些组合物作为活性剂用于治疗由病毒引起的人类和动物疾病。
US3940519A
申请人:——
公开号:US3940519A
公开(公告)日:1976-02-24
US4239761A
申请人:——
公开号:US4239761A
公开(公告)日:1980-12-16
Prozorovskii, V. B.; Pavlova, L. V.; Suslova, I. M., Russian Journal of Applied Chemistry, 1995, vol. 68, # 4.2, p. 589 - 593
作者:Prozorovskii, V. B.、Pavlova, L. V.、Suslova, I. M.、Belozerova, L. V.、Kokushkina, A. V.、Sazonova, A. V.
DOI:——
日期:——
Basically substituted ureas and processes for the treatment of virus
The present invention is related to new basically substituted ureas having the general Formula I ##STR1## and the pharmaceutically acceptable acid addition salts thereof which produce an improved antiviral activity against DNS- and RNS-viruses. The invention is further related to the treatment of humans or animals suffering from diseases caused by viruses by administering compositions containing such ureas or salts thereof as active agent.